$PLUR
Pluri Inc. Common Stock
XNAS•Health Care•Biological Products, (No Diagnostic Substances)
$1.00
▼-7.41%-$0.080
Subscriptions are live. Early access $24.99/mo, or start with 5 free premium days.
Plans & pricingDonatePluri Inc. Common Stock
XNAS•Health Care•Biological Products, (No Diagnostic Substances)
Why is PLUR down today? It is at $1.00 (-7.41%). See the catalyst behind the move, real-time alerts the moment PLUR spikes, and full due diligence on PLUR — key stats, earnings, dilution and insider activity. Free.
Be first to know when $PLUR makes an unusual move. Create a free account to track $PLUR, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Here is the latest on PLUR from our scanner (live price and day move above). A move this size is almost always tied to a specific catalyst. Most of the time that is an earnings report, a guidance update, or a company announcement. If none is shown above, the release may not be in our news feed yet. It will show up here as soon as it is.
| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Manieu Alexandre Weinstein Director | Acquired (grant/award) | +180K 1.5% of company | added 100% | 191K | n/a | Aug 20, 26 |
Shorrer Doron Director | Acquired (grant/award) | +32K 0.3% of company | added 100% | 38K | n/a | Aug 20, 26 |
Manieu Alexandre Weinstein Director | Acquired (grant/award) | +641 | added 10% | 7K | n/a | Jun 30, 26 |
Manieu Alexandre Weinstein Director | Acquired (grant/award) | +313K 2.5% of company | added 15% | 2.39M | $625K at $2.00 | Apr 21, 26 |
Manieu Alexandre Weinstein Director | Acquired (grant/award) | +313K 2.5% of company | added 50% | 938K | $625K at $2.00 | Mar 31, 26 |
Manieu Alexandre Weinstein Director | Acquired (grant/award) | +625K 5.1% of company | added 100% | 1.08M | $1.3M at $2.00 | Dec 8, 25 |
Aberman Zami Director | Acquired (grant/award) | +346 | added 0.2% | 144K | n/a | Dec 4, 25 |
Shemesh-Rasmussen Maital Director | Acquired (grant/award) | +699 | added 3.8% | 19K | n/a | Dec 4, 25 |
Zalts Liat Officer | Acquired (grant/award) | +4K 0.03% of company | added 4.1% | 93K | n/a | Dec 4, 25 |
Levi Rami Avraham Director | Acquired (grant/award) | +653 | added 3.6% | 19K | n/a | Dec 4, 25 |
Yanay Yaky Officer | Acquired (grant/award) | +7K 0.05% of company | added 1.3% | 498K | n/a | Dec 4, 25 |
Ajchenbaum Eitan Director | Acquired (grant/award) | +668 | added 5.7% | 12K | n/a | Dec 4, 25 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Blend of news sentiment, today’s move, and community votes. Not investment advice.
Comparable names in biological products, (no diagnostic substances), closest in size first.
Here is the latest on PLUR from our scanner (live price and day move above). A move this size is almost always tied to a specific catalyst. Most of the time that is an earnings report, a guidance update, or a company announcement. If none is shown above, the release may not be in our news feed yet. It will show up here as soon as it is.
PLUR last traded at $1.00, down 7.41% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
Pluri Inc. Common Stock (PLUR) is next expected to report earnings on Wednesday, November 11, 2026, about 52 days away. Earnings reports often cause large overnight gaps, so many traders manage risk around the date. The date can shift until the company officially confirms it.
The PLUR Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged PLUR 0 times in the last 30 days.
PLUR (Pluri Inc. Common Stock) trades on XNAS, with a market cap of about $13M in the Biological Products, (No Diagnostic Substances) sector.
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge PLUR for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.
$PLUR discussion
Sign in to ask a question or join the discussion.